204 related articles for article (PubMed ID: 29951658)
1. Versatile coordination of acetazolamide to ruthenium(ii) p-cymene complexes and preliminary cytotoxicity studies.
Biancalana L; Batchelor LK; Ciancaleoni G; Zacchini S; Pampaloni G; Dyson PJ; Marchetti F
Dalton Trans; 2018 Jul; 47(28):9367-9384. PubMed ID: 29951658
[TBL] [Abstract][Full Text] [Related]
2. α-Diimines as Versatile, Derivatizable Ligands in Ruthenium(II) p-Cymene Anticancer Complexes.
Biancalana L; Batchelor LK; Funaioli T; Zacchini S; Bortoluzzi M; Pampaloni G; Dyson PJ; Marchetti F
Inorg Chem; 2018 Jun; 57(11):6669-6685. PubMed ID: 29790340
[TBL] [Abstract][Full Text] [Related]
3. Role of the (pseudo)halido ligand in ruthenium(II)
Biancalana L; Zanda E; Hadiji M; Zacchini S; Pratesi A; Pampaloni G; Dyson PJ; Marchetti F
Dalton Trans; 2021 Nov; 50(43):15760-15777. PubMed ID: 34704998
[TBL] [Abstract][Full Text] [Related]
4. DNA targeting half sandwich Ru(II)-
Mondal A; Sen U; Roy N; Muthukumar V; Sahoo SK; Bose B; Paira P
Dalton Trans; 2021 Jan; 50(3):979-997. PubMed ID: 33355328
[TBL] [Abstract][Full Text] [Related]
5. Coordination-driven self-assembly of ruthenium(ii) architectures: synthesis, characterization and cytotoxicity studies.
Adeyemo AA; Shettar A; Bhat IA; Kondaiah P; Mukherjee PS
Dalton Trans; 2018 Jun; 47(25):8466-8475. PubMed ID: 29901668
[TBL] [Abstract][Full Text] [Related]
6. Ru
Lenis-Rojas OA; Robalo MP; Tomaz AI; Carvalho A; Fernandes AR; Marques F; Folgueira M; Yáñez J; Vázquez-García D; López Torres M; Fernández A; Fernández JJ
Inorg Chem; 2018 Nov; 57(21):13150-13166. PubMed ID: 30339386
[TBL] [Abstract][Full Text] [Related]
7. Tuning the cytotoxicity of ruthenium(ii) para-cymene complexes by mono-substitution at a triphenylphosphine/phenoxydiphenylphosphine ligand.
Biancalana L; Zacchini S; Ferri N; Lupo MG; Pampaloni G; Marchetti F
Dalton Trans; 2017 Dec; 46(47):16589-16604. PubMed ID: 29164209
[TBL] [Abstract][Full Text] [Related]
8. Comparative solution equilibrium studies of antitumor ruthenium(η
Dömötör O; Pape VFS; May NV; Szakács G; Enyedy ÉA
Dalton Trans; 2017 Mar; 46(13):4382-4396. PubMed ID: 28287667
[TBL] [Abstract][Full Text] [Related]
9. Luminescent anticancer Ru(II)-arenebipyridine and phenanthroline complexes: Synthesis, characterization, DFT studies, biological interactions and cellular imaging application.
P K A; Paira P
J Inorg Biochem; 2020 Jul; 208():111099. PubMed ID: 32460056
[TBL] [Abstract][Full Text] [Related]
10. Highly active neutral ruthenium(II) arene complexes: synthesis, characterization, and investigation of their anticancer properties.
Ludwig G; Kaluđerović GN; Bette M; Block M; Paschke R; Steinborn D
J Inorg Biochem; 2012 Aug; 113():77-82. PubMed ID: 22698819
[TBL] [Abstract][Full Text] [Related]
11. Self-Assembly of Discrete Ru
Ajibola Adeyemo A; Shettar A; Bhat IA; Kondaiah P; Mukherjee PS
Inorg Chem; 2017 Jan; 56(1):608-617. PubMed ID: 27997153
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic Ru
Sarkar A; Acharya S; Khushvant K; Purkait K; Mukherjee A
Dalton Trans; 2019 May; 48(21):7187-7197. PubMed ID: 30601545
[TBL] [Abstract][Full Text] [Related]
13. Development of novel ruthenium(II)-arene complexes displaying potent anticancer effects in glioblastoma cells.
Kumar P; Mondal I; Kulshreshtha R; Patra AK
Dalton Trans; 2020 Oct; 49(38):13294-13310. PubMed ID: 32936191
[TBL] [Abstract][Full Text] [Related]
14. Anticancer activity and DNA binding of a bifunctional Ru(II) arene aqua-complex with the 2,4-diamino-6-(2-pyridyl)-1,3,5-triazine ligand.
Busto N; Valladolid J; Martínez-Alonso M; Lozano HJ; Jalón FA; Manzano BR; Rodríguez AM; Carrión MC; Biver T; Leal JM; Espino G; García B
Inorg Chem; 2013 Sep; 52(17):9962-74. PubMed ID: 23957818
[TBL] [Abstract][Full Text] [Related]
15. Water-soluble Ru(II)- and Ru(III)-halide-PTA complexes (PTA=1,3,5-triaza-7-phosphaadamantane): Chemical and biological properties.
Battistin F; Scaletti F; Balducci G; Pillozzi S; Arcangeli A; Messori L; Alessio E
J Inorg Biochem; 2016 Jul; 160():180-8. PubMed ID: 26920229
[TBL] [Abstract][Full Text] [Related]
16. Phenylazo-pyridine and phenylazo-pyrazole chlorido ruthenium(II) arene complexes: arene loss, aquation, and cancer cell cytotoxicity.
Dougan SJ; Melchart M; Habtemariam A; Parsons S; Sadler PJ
Inorg Chem; 2006 Dec; 45(26):10882-94. PubMed ID: 17173447
[TBL] [Abstract][Full Text] [Related]
17. [(η(6)-p-cymene)Ru(H2O)3](2+) binding capability of aminohydroxamates - A solution and solid state study.
Parajdi-Losonczi PL; Bényei AC; Kováts É; Timári I; Muchova TR; Novohradsky V; Kasparkova J; Buglyó P
J Inorg Biochem; 2016 Jul; 160():236-45. PubMed ID: 26971623
[TBL] [Abstract][Full Text] [Related]
18. Luminescent naphthalimide-tagged ruthenium(ii)-arene complexes: cellular imaging, photocytotoxicity and transferrin binding.
Srivastava P; Verma M; Kumar A; Srivastava P; Mishra R; Sivakumar S; Patra AK
Dalton Trans; 2021 Mar; 50(10):3629-3640. PubMed ID: 33625414
[TBL] [Abstract][Full Text] [Related]
19. Biological Potential of Halfsandwich Ruthenium(II) and Iridium (III) Complexes.
Ludwig G; Mojić M; Bulatović M; Mijatović S; Maksimović-Ivanić D; Steinborn D; Kaluđerović GN
Anticancer Agents Med Chem; 2016; 16(11):1455-1460. PubMed ID: 26510901
[TBL] [Abstract][Full Text] [Related]
20. Electrochemical, mechanistic, and DFT studies of amine derived diphosphines containing Ru(II)-cymene complexes with potent
da Silva JP; Fuganti O; Kramer MG; Facchin G; Aquino LEN; Ellena J; Back DF; Gondim ACS; Sousa EHS; Lopes LGF; Machado S; Guimarães IDL; Wohnrath K; de Araujo MP
Dalton Trans; 2020 Nov; 49(45):16498-16514. PubMed ID: 33206073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
